Citation Impact

Citing Papers

Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
2011
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor–Mediated Podocyte β3-integrin Activation
2015
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis
2002
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
The molecular biology and clinical features of amyloid neuropathy
2007
A Rare Case of IgG4-Related Sclerosing Disease of the Maxillary Sinus Associated With Bone Destruction
2009
International Consensus Diagnostic Criteria for Autoimmune Pancreatitis
2011 Standout
Amyloid Heart Disease
2010
Immunoglobulin G4: an odd antibody
2009
TGF-β: the master regulator of fibrosis
2016 Standout
Amyloid diseases of the heart: current and future therapies
2012
Serum levels of IgG and IgG4 in Hashimoto thyroiditis
2013
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Lymphadenopathy of IgG4-related Sclerosing Disease
2008
Systematic review: proton pump inhibitor‐associated acute interstitial nephritis
2007
Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?
2013 Standout
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
IgG4-Related Disease
2012 Standout
Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome
2007
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
2009
A clinical overview of IgG4-related systemic disease
2010
Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease
2007
Chronic kidney disease
2011 Standout
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome
2006
IgG4-positive Plasma Cells in Inflammatory Abdominal Aortic Aneurysm: The Possibility of an Aortic Manifestation of IgG4-related Sclerosing Disease
2008
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic Disorders
2011
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
2003
Riedel's Thyroiditis and Multifocal Fibrosclerosis are part of the IgG4‐related systemic disease spectrum
2010
Organ Transplantation in Hereditary Apolipoprotein AI Amyloidosis
2006
Systemic amyloidosis
2015 Standout
Acute kidney injury following proton pump inhibitor therapy
2006
IgG4-related Sclerosing Disease
2010
IgG4-related disease
2014 Standout
Immunoglobulin G4–related Lung Disease: CT Findings with Pathologic Correlations
2009
Focal Segmental Glomerulosclerosis
2011
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis
2007
Rethinking Ormond’s Disease
2013
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Autoimmune Pankreatitis
2009
Role of Th2 Cells in IgG4-Related Lacrimal Gland Enlargement
2010
Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
2010
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies
2004
Molecular Mechanisms of Amyloidosis
2003 Standout
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes
2019
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
Clinical consequences of polypharmacy in elderly
2013 Standout
The effect of free health care on polypharmacy: a comparison of propensity score methods and multivariable regression to account for confounding
2014
Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years’ experience
2016
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
IgG4-Related Esophageal Disease Presenting as Esophagitis Dissecans Superficialis With Chronic Strictures
2014
Interventions to improve the appropriate use of polypharmacy for older people
2014
Management of idiopathic membranous nephropathy
2010

Works of Catherine Wall being referenced

Idiopathic membranous nephropathy: Definition and relevance of a partial remission
2004
Focal and Segmental Glomerulosclerosis
2005
Trends in co‐prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland
2010
Hyper-IgG4 disease: report and characterisation of a new disease
2006
CLINICAL AND BIOCHEMICAL OUTCOME OF HEPATORENAL TRANSPLANTATION FOR HEREDITARY SYSTEMIC AMYLOIDOSIS ASSOCIATED WITH APOLIPOPROTEIN AI Gly26Arg1
2001
Hypercalcaemia and acute interstitial nephritis associated with omeprazole therapy
2000
Impact of the Collaborative Pharmaceutical Care at Tallaght Hospital (PACT) model on medication appropriateness of older patients
2015
Colchicine toxicity in renal patients – Are we paying attention?
2015
Rankless by CCL
2026